Follow-up strategies and management of recurrence in urologic oncology bladder cancer: Invasive bladder cancer Journal Article


Authors: Bochner, B. H.; Montie, J. E.; Lee, C. T.
Article Title: Follow-up strategies and management of recurrence in urologic oncology bladder cancer: Invasive bladder cancer
Abstract: A surveillance program following cystectomy should consider a patient's individual risk for the development of local and distant recurrences and any specific needs related to the urinary tract reconstruction performed (Table 1). Well-documented recurrence patterns following cystectomy are available from many large surgical series and provide the background information needed for tailoring follow-up based on pathologic criteria. Economic issues also must be considered, given that the health care-related expenses of treating and following patients with bladder cancer is twice as much as that expended for the treatment of prostate cancer. Because of the ever-increasing fiscal constraints placed on clinicians, risk-adjusted follow-up strategies are reasonable, but will require prospective evaluation to validate their appropriateness.
Keywords: cancer chemotherapy; cancer survival; treatment outcome; cancer surgery; surgical technique; review; cancer localization; cancer recurrence; plastic surgery; cisplatin; doxorubicin; cancer growth; patient selection; side effect; gemcitabine; paclitaxel; cancer adjuvant therapy; methotrexate; cancer staging; nuclear magnetic resonance imaging; positron emission tomography; recurrence risk; follow up; antineoplastic agent; cancer diagnosis; pelvis lymph node; laparoscopic surgery; preoperative evaluation; cancer palliative therapy; cytology; cancer susceptibility; cancer immunotherapy; metastasis; computer assisted tomography; neoplasm recurrence, local; pelvis lymphadenectomy; tumor biopsy; bladder cancer; urinary bladder neoplasms; ifosfamide; vinblastine; high risk patient; docetaxel; postoperative complication; prophylaxis; cystectomy; urinary diversion; nephroureterectomy; invasive carcinoma; urogenital tract tumor; malabsorption; ureter; endoscopy; transitional cell carcinoma; metabolic disorder; non invasive measurement; electrolyte disturbance; cyanocobalamin; bladder neck; colostomy; urolithiasis; intravenous pyelography; retrograde pyelography; metabolic acidosis; megaloblastic anemia; humans; prognosis; human; male; priority journal; ureterectomy
Journal Title: Urologic Clinics of North America
Volume: 30
Issue: 4
ISSN: 0094-0143
Publisher: W.B. Saunders Co-Elsevier Inc.  
Date Published: 2003-11-01
Start Page: 777
End Page: 789
Language: English
DOI: 10.1016/s0094-0143(03)00061-2
PUBMED: 14680314
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 25 September 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bernard Bochner
    468 Bochner